| +4.33 / +7.99%|
The 20 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 56.00, with a high estimate of 63.00 and a low estimate of 36.00. The median estimate represents a -4.26% decrease from the last price of 58.49.
The current consensus among 24 polled investment analysts is to Hold stock in Bristol-Myers Squibb Co. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.